Pharmaceutical - Financial, Ablynx

Filter

Current filters:

FinancialAblynx

Popular Filters

Boehringer Ingelheim initiates Phase I study with Ablynx nanobody triggering milestone payment

Boehringer Ingelheim initiates Phase I study with Ablynx nanobody triggering milestone payment

29-10-2013

Ablynx says its partner Boehringer Ingelheim has dosed the first healthy volunteers in a Phase I clinical…

AblynxBoehringer IngelheimEuropeFinancialNanobodyNeurologicalPharmaceuticalResearch

Ablynx earns milestone from Merck Serono

13-12-2011

Belgium’s Ablynx (Euronext Brussels: ABLX) says it will earn a 1 million-euro ($1.3 million) from…

AblynxBiotechnologyFinancialImmunologicalsMerck KGaAMerck SeronoPharmaceuticalResearch

Back to top